0001654954-18-009332.txt : 20180817 0001654954-18-009332.hdr.sgml : 20180817 20180817164234 ACCESSION NUMBER: 0001654954-18-009332 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180817 DATE AS OF CHANGE: 20180817 EFFECTIVENESS DATE: 20180817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-319563 FILM NUMBER: 181026218 BUSINESS ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 D 1 primary_doc.xml X0708 D LIVE 0000109657 GT Biopharma, Inc. 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 800-304-9888 FLORIDA Oxis International Inc. DDI Pharmaceuticals Inc. Diagnostic Data Inc. /DE/ OXIS INTERNATIONAL INC DDI PHARMACEUTICALS INC DIAGNOSTIC DATA INC /DE/ Corporation true Steven Weldon 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Director Executive Officer Anthony J. Cataldo 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Director Kathleen Clarence-Smith 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Director Geoffrey B. Davis 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Director Peter Kiener 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Director Jon Bonfiglio 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Director Raymond Urbanski 100 SOUTH ASHLEY DRIVE STE 600 TAMPA FL FLORIDA 33602 Executive Officer Biotechnology Decline to Disclose 06b false 2018-08-02 false true false 0 5140000 5140000 0 false 13 0 0 0 None, other than compensation to executive officers in their roles as employees. GT Biopharma, Inc. /s/ Steven Weldon Steven Weldon Chief Financial Officer 2018-08-16